Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
9.34
+0.01 (0.11%)
Nov 11, 2026, 10:16 AM EST - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $183.29 million as of November 11, 2026. It is the 21,048th most valuable company in the world and the 3,600th biggest in the United States. Its market cap has decreased by 64.69% in one year.
Market Cap
183.29M
Enterprise Value
-61.06M
1-Year Change
-64.69%
Global Rank
Country Rank
#3,600 United States
Category
ChartMarket Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $183.29M, a decrease of -52.43%. That is a compound annual growth rate of -10.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 183.29M | -70.45% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 194.48M |
| InflaRx | 191.58M |
| BridgeBio Oncology Therapeutics | 185.20M |
| Bright Minds Biosciences | 182.72M |
| Whitehawk Therapeutics | 182.14M |
| Invivyd | 177.71M |
| ALX Oncology Holdings | 176.30M |
| Sutro Biopharma | 175.76M |